Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107:28–36

Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23:469–480

Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJB et al (2012) Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort. Cancer Res 72:5328–5337

Algire C, Amrein L, Zakikhani M, Panasci L, Pollak M (2010) Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer 17:351–360

Augustin LS, Dal Maso L, La Vecchia C, Parpinel M, Negri E, Vaccarella S et al (2001) Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol 12:1533–1538

Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545

Bassols J, Ortega FJ, Moreno-Navarrete JM, Peral B, Ricart W, Fernandez-Real JM (2009) Study of the proinflammatory role of human differentiated omental adipocytes. J Cell Biochem 107:1107–1117

Beddy P, Howard J, McMahon C, Knox M, de Blacam C, Ravi N et al (2010) Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 97:1028–1034

Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J et al (2010) Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 171:892–902

Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J et al (2006) A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 164:652–664

Brand-Miller JC, Holt SH, Pawlak DB, McMillan J (2002) Glycemic index and obesity. Am J Clin Nutr 76:281S–285S

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

Coe PO, O’Reilly DA, Renehan AG (2014) Excess adiposity and gastrointestinal cancer. Br J Surg 101:1518–1531

Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11:385–391

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081

Cook KS, Min HY, Johnson D, Chaplinsky RJ, Flier JS, Hunt CR et al (1987) Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 237:402–405

Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA et al (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81:341–354

Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522

Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B et al (2012) A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat 132(3):993–1000

Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R et al (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53:1285–1292

Dalamaga M, Diakopoulos KN, Mantzoros CS (2012) The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33:547–594

Despres JP (2006) Is visceral obesity the cause of the metabolic syndrome? Ann Med 38:52–63

Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887

Dirx MJM, Zeegers MPA, Dagnelie PC, van den Bogaard T, van den Brandt PA (2003) Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106:766–770

Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV (2010) Obesity and gastrointestinal cancer. B J Surg 97:628–642

Donohoe CL, Doyle SL, McGarrigle S, Cathcart MC, Daly E, O’Grady A et al (2012) Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma. Br J Surg 99:387–396

Drewnowski A (2000) Nutrition transition and global dietary trends. Nutrition 16:486–487

Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN et al (2011) Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29:32–39

Eaton SB, Konner M, Shostak M (1988) Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 84:739–749

Ellis LM, Hicklin DJ (2009) Resistance to targeted therapies: refining anticancer therapy in the era of molecular oncology. Clin Cancer Res 15:7471–7478

Flier JS, Cook KS, Usher P, Spiegelman BM (1987) Severely impaired adipsin expression in genetic and acquired obesity. Science 237:405–408

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments. Circulation 116:39–48

Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P et al (2001) Dietary glycemic load and colorectal cancer risk. Ann Oncol 12:173–178

Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A et al (2008) The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23–37

Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847–850

Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S (1987) Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54–59

Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129–139

Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207:12–22

Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6:164–179

Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86:836S–842S

Grossmann ME, Cleary MP (2012) The balance between leptin and adiponectin in the control of carcinogenesis—focus on mammary tumorigenesis. Biochimie 94:2164–2171

Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D’Alessandro R et al (2009) Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 29:3321–3327

Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H et al (2011) Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer 128:1890–1898

Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U (2012) Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380:247–257

Hamer M, Sabia S, Batty GD, Shipley MJ, Tabák AG, Singh-Manoux A et al (2012) Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II Cohort Study. Circulation 126:928–933

Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45–52

Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T et al (2010) Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 22:281–288